Relations between liver cadmium, cumulative exposure, and renal function in cadmium alloy workers

H. J. Mason, A. G. Davison, A. L. Wright, C. J.G. Guthrie, P. M. Fayers, K. M. Venables, N. J. Smith, D. R. Chettle, D. M. Franklin, M. C. Scott, H. Holden, D. Gompertz, A. J. Newman-Taylor

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Detailed biochemical investigations of renal function were made on 75 male workers exposed to cadmium and an equal number of referents matched for age, sex, and employment status. The exposed group consisted of current and retired workers who had been employed in the manufacture of copper-cadmium alloy at a single factory in the United Kingdom for periods of up to 39 years and for whom cumulative cadmium exposure indices could be calculated. In vivo measurements of liver and kidney cadmium burden were made on exposed and referent workers using a transportable neutron activation analysis facility. Significant increases in the urinary excretion of albumin, retinol binding protein, β2 microglobulin, N-acetylglucosaminidase (NAG), alkaline phosphatase, γ-glutamyl transferase and significant decreases in the renal reabsorption of calcium, urate and phosphate were found in the exposed group compared with the referent group. Measures of glomerular filtration rate (GFR) (creatinine clearance, serum creatinine, and β2 microglobulin) indicated a reduction in GFR in the exposed population. Many of these tubular and glomerular function indicators were significantly correlated with both cumulative exposure index and liver cadmium burden. Using cumulative exposure index and liver cadmium as estimates of dose, a two phase linear regression model was applied to identify an infection point signifying a threshold level above which changes in renal function occur. Many biochemical variables fitted this model; urinary total protein, retinol binding protein, albumin, and β2 microglobulin gave similar inflection points at cumulative exposure levels of about 1100 y.μg/m3 whereas changes in the tubular reabsorption of urate and phosphate occurred at higher cumulative exposure indices. Measures of GFR, although fitting the threshold model did not give well defined inflection points. Fewer variables fitted the two phase model using liver cadmium; those that did gave threshold levels in the range 20.3-55.1 ppm. When cadmium workers with cumulative exposure indices of less than 100 y.*g/m3 were compared with their respective referents only serum β2 microglobulin and urinary NAG were significantly increased in the exposed group and these differences were not related to the degree of cadmium exposure. Simple dose response analysis of the full exposed group showed a greatly increased incidence of tubular proteinuria when the cumulative cadmium exposure index was greater than 1000 y.μg/m3. These cumulative exposure indices are equivalent to about 20-22 years exposure at 50 μg/m3, the current occupational exposure limit used in many countries.

Original languageEnglish
Pages (from-to)793-802
Number of pages10
JournalBritish Journal of Industrial Medicine
Volume45
Issue number12
Publication statusPublished - 1 Dec 1988

Fingerprint

Cadmium
Kidney
Liver
Cellular Retinol-Binding Proteins
Glomerular Filtration Rate
Acetylglucosaminidase
Uric Acid
Albumins
Linear Models
Creatinine
Neutron Activation Analysis
Occupational Exposure
Transferases
Serum
Proteinuria
Alkaline Phosphatase
Copper
Phosphates
Incidence
Infection

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Mason, H. J., Davison, A. G., Wright, A. L., Guthrie, C. J. G., Fayers, P. M., Venables, K. M., ... Newman-Taylor, A. J. (1988). Relations between liver cadmium, cumulative exposure, and renal function in cadmium alloy workers. British Journal of Industrial Medicine, 45(12), 793-802.

Relations between liver cadmium, cumulative exposure, and renal function in cadmium alloy workers. / Mason, H. J.; Davison, A. G.; Wright, A. L.; Guthrie, C. J.G.; Fayers, P. M.; Venables, K. M.; Smith, N. J.; Chettle, D. R.; Franklin, D. M.; Scott, M. C.; Holden, H.; Gompertz, D.; Newman-Taylor, A. J.

In: British Journal of Industrial Medicine, Vol. 45, No. 12, 01.12.1988, p. 793-802.

Research output: Contribution to journalArticle

Mason, HJ, Davison, AG, Wright, AL, Guthrie, CJG, Fayers, PM, Venables, KM, Smith, NJ, Chettle, DR, Franklin, DM, Scott, MC, Holden, H, Gompertz, D & Newman-Taylor, AJ 1988, 'Relations between liver cadmium, cumulative exposure, and renal function in cadmium alloy workers', British Journal of Industrial Medicine, vol. 45, no. 12, pp. 793-802.
Mason, H. J. ; Davison, A. G. ; Wright, A. L. ; Guthrie, C. J.G. ; Fayers, P. M. ; Venables, K. M. ; Smith, N. J. ; Chettle, D. R. ; Franklin, D. M. ; Scott, M. C. ; Holden, H. ; Gompertz, D. ; Newman-Taylor, A. J. / Relations between liver cadmium, cumulative exposure, and renal function in cadmium alloy workers. In: British Journal of Industrial Medicine. 1988 ; Vol. 45, No. 12. pp. 793-802.
@article{ea03d6cf93754c299d90a2d6cfe94892,
title = "Relations between liver cadmium, cumulative exposure, and renal function in cadmium alloy workers",
abstract = "Detailed biochemical investigations of renal function were made on 75 male workers exposed to cadmium and an equal number of referents matched for age, sex, and employment status. The exposed group consisted of current and retired workers who had been employed in the manufacture of copper-cadmium alloy at a single factory in the United Kingdom for periods of up to 39 years and for whom cumulative cadmium exposure indices could be calculated. In vivo measurements of liver and kidney cadmium burden were made on exposed and referent workers using a transportable neutron activation analysis facility. Significant increases in the urinary excretion of albumin, retinol binding protein, β2 microglobulin, N-acetylglucosaminidase (NAG), alkaline phosphatase, γ-glutamyl transferase and significant decreases in the renal reabsorption of calcium, urate and phosphate were found in the exposed group compared with the referent group. Measures of glomerular filtration rate (GFR) (creatinine clearance, serum creatinine, and β2 microglobulin) indicated a reduction in GFR in the exposed population. Many of these tubular and glomerular function indicators were significantly correlated with both cumulative exposure index and liver cadmium burden. Using cumulative exposure index and liver cadmium as estimates of dose, a two phase linear regression model was applied to identify an infection point signifying a threshold level above which changes in renal function occur. Many biochemical variables fitted this model; urinary total protein, retinol binding protein, albumin, and β2 microglobulin gave similar inflection points at cumulative exposure levels of about 1100 y.μg/m3 whereas changes in the tubular reabsorption of urate and phosphate occurred at higher cumulative exposure indices. Measures of GFR, although fitting the threshold model did not give well defined inflection points. Fewer variables fitted the two phase model using liver cadmium; those that did gave threshold levels in the range 20.3-55.1 ppm. When cadmium workers with cumulative exposure indices of less than 100 y.*g/m3 were compared with their respective referents only serum β2 microglobulin and urinary NAG were significantly increased in the exposed group and these differences were not related to the degree of cadmium exposure. Simple dose response analysis of the full exposed group showed a greatly increased incidence of tubular proteinuria when the cumulative cadmium exposure index was greater than 1000 y.μg/m3. These cumulative exposure indices are equivalent to about 20-22 years exposure at 50 μg/m3, the current occupational exposure limit used in many countries.",
author = "Mason, {H. J.} and Davison, {A. G.} and Wright, {A. L.} and Guthrie, {C. J.G.} and Fayers, {P. M.} and Venables, {K. M.} and Smith, {N. J.} and Chettle, {D. R.} and Franklin, {D. M.} and Scott, {M. C.} and H. Holden and D. Gompertz and Newman-Taylor, {A. J.}",
year = "1988",
month = "12",
day = "1",
language = "English",
volume = "45",
pages = "793--802",
journal = "British Journal of Industrial Medicine",
issn = "0007-1072",
publisher = "BMJ Publishing Group",
number = "12",

}

TY - JOUR

T1 - Relations between liver cadmium, cumulative exposure, and renal function in cadmium alloy workers

AU - Mason, H. J.

AU - Davison, A. G.

AU - Wright, A. L.

AU - Guthrie, C. J.G.

AU - Fayers, P. M.

AU - Venables, K. M.

AU - Smith, N. J.

AU - Chettle, D. R.

AU - Franklin, D. M.

AU - Scott, M. C.

AU - Holden, H.

AU - Gompertz, D.

AU - Newman-Taylor, A. J.

PY - 1988/12/1

Y1 - 1988/12/1

N2 - Detailed biochemical investigations of renal function were made on 75 male workers exposed to cadmium and an equal number of referents matched for age, sex, and employment status. The exposed group consisted of current and retired workers who had been employed in the manufacture of copper-cadmium alloy at a single factory in the United Kingdom for periods of up to 39 years and for whom cumulative cadmium exposure indices could be calculated. In vivo measurements of liver and kidney cadmium burden were made on exposed and referent workers using a transportable neutron activation analysis facility. Significant increases in the urinary excretion of albumin, retinol binding protein, β2 microglobulin, N-acetylglucosaminidase (NAG), alkaline phosphatase, γ-glutamyl transferase and significant decreases in the renal reabsorption of calcium, urate and phosphate were found in the exposed group compared with the referent group. Measures of glomerular filtration rate (GFR) (creatinine clearance, serum creatinine, and β2 microglobulin) indicated a reduction in GFR in the exposed population. Many of these tubular and glomerular function indicators were significantly correlated with both cumulative exposure index and liver cadmium burden. Using cumulative exposure index and liver cadmium as estimates of dose, a two phase linear regression model was applied to identify an infection point signifying a threshold level above which changes in renal function occur. Many biochemical variables fitted this model; urinary total protein, retinol binding protein, albumin, and β2 microglobulin gave similar inflection points at cumulative exposure levels of about 1100 y.μg/m3 whereas changes in the tubular reabsorption of urate and phosphate occurred at higher cumulative exposure indices. Measures of GFR, although fitting the threshold model did not give well defined inflection points. Fewer variables fitted the two phase model using liver cadmium; those that did gave threshold levels in the range 20.3-55.1 ppm. When cadmium workers with cumulative exposure indices of less than 100 y.*g/m3 were compared with their respective referents only serum β2 microglobulin and urinary NAG were significantly increased in the exposed group and these differences were not related to the degree of cadmium exposure. Simple dose response analysis of the full exposed group showed a greatly increased incidence of tubular proteinuria when the cumulative cadmium exposure index was greater than 1000 y.μg/m3. These cumulative exposure indices are equivalent to about 20-22 years exposure at 50 μg/m3, the current occupational exposure limit used in many countries.

AB - Detailed biochemical investigations of renal function were made on 75 male workers exposed to cadmium and an equal number of referents matched for age, sex, and employment status. The exposed group consisted of current and retired workers who had been employed in the manufacture of copper-cadmium alloy at a single factory in the United Kingdom for periods of up to 39 years and for whom cumulative cadmium exposure indices could be calculated. In vivo measurements of liver and kidney cadmium burden were made on exposed and referent workers using a transportable neutron activation analysis facility. Significant increases in the urinary excretion of albumin, retinol binding protein, β2 microglobulin, N-acetylglucosaminidase (NAG), alkaline phosphatase, γ-glutamyl transferase and significant decreases in the renal reabsorption of calcium, urate and phosphate were found in the exposed group compared with the referent group. Measures of glomerular filtration rate (GFR) (creatinine clearance, serum creatinine, and β2 microglobulin) indicated a reduction in GFR in the exposed population. Many of these tubular and glomerular function indicators were significantly correlated with both cumulative exposure index and liver cadmium burden. Using cumulative exposure index and liver cadmium as estimates of dose, a two phase linear regression model was applied to identify an infection point signifying a threshold level above which changes in renal function occur. Many biochemical variables fitted this model; urinary total protein, retinol binding protein, albumin, and β2 microglobulin gave similar inflection points at cumulative exposure levels of about 1100 y.μg/m3 whereas changes in the tubular reabsorption of urate and phosphate occurred at higher cumulative exposure indices. Measures of GFR, although fitting the threshold model did not give well defined inflection points. Fewer variables fitted the two phase model using liver cadmium; those that did gave threshold levels in the range 20.3-55.1 ppm. When cadmium workers with cumulative exposure indices of less than 100 y.*g/m3 were compared with their respective referents only serum β2 microglobulin and urinary NAG were significantly increased in the exposed group and these differences were not related to the degree of cadmium exposure. Simple dose response analysis of the full exposed group showed a greatly increased incidence of tubular proteinuria when the cumulative cadmium exposure index was greater than 1000 y.μg/m3. These cumulative exposure indices are equivalent to about 20-22 years exposure at 50 μg/m3, the current occupational exposure limit used in many countries.

UR - http://www.scopus.com/inward/record.url?scp=0024267686&partnerID=8YFLogxK

M3 - Article

VL - 45

SP - 793

EP - 802

JO - British Journal of Industrial Medicine

JF - British Journal of Industrial Medicine

SN - 0007-1072

IS - 12

ER -